ATE229341T1 - Lektinzusammenstellungen und deren verwendung - Google Patents
Lektinzusammenstellungen und deren verwendungInfo
- Publication number
- ATE229341T1 ATE229341T1 AT97927282T AT97927282T ATE229341T1 AT E229341 T1 ATE229341 T1 AT E229341T1 AT 97927282 T AT97927282 T AT 97927282T AT 97927282 T AT97927282 T AT 97927282T AT E229341 T1 ATE229341 T1 AT E229341T1
- Authority
- AT
- Austria
- Prior art keywords
- compositions
- manufacture
- reduction
- compilations
- lectin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/168—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/185—Vegetable proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8962—Allium, e.g. garden onion, leek, garlic or chives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Polymers & Plastics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Gastroenterology & Hepatology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Obesity (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9613070.3A GB9613070D0 (en) | 1996-06-21 | 1996-06-21 | Dietary lectins |
| PCT/GB1997/001668 WO1997049420A1 (en) | 1996-06-21 | 1997-06-20 | Lectin compositions and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE229341T1 true ATE229341T1 (de) | 2002-12-15 |
Family
ID=10795697
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT97927282T ATE229341T1 (de) | 1996-06-21 | 1997-06-20 | Lektinzusammenstellungen und deren verwendung |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP0942741B1 (de) |
| JP (1) | JP4379924B2 (de) |
| CN (1) | CN1157225C (de) |
| AT (1) | ATE229341T1 (de) |
| AU (1) | AU738386B2 (de) |
| CA (1) | CA2258503C (de) |
| DE (1) | DE69717849T2 (de) |
| DK (1) | DK0942741T3 (de) |
| ES (1) | ES2190535T3 (de) |
| GB (1) | GB9613070D0 (de) |
| NO (1) | NO323880B1 (de) |
| NZ (1) | NZ333411A (de) |
| PL (1) | PL190301B1 (de) |
| PT (1) | PT942741E (de) |
| RU (1) | RU2202361C2 (de) |
| WO (1) | WO1997049420A1 (de) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020132017A1 (en) | 1996-12-09 | 2002-09-19 | Moore Jeffrey G. | Composition and method for preserving progenitor cells |
| US6310195B1 (en) | 1997-06-24 | 2001-10-30 | Imclone Systems Incorporated | Nucleic acid encoding a lectin-derived progenitor cell preservation factor |
| US6991794B1 (en) | 1997-06-24 | 2006-01-31 | Imclone Systems Incorporated | Progenitor cell preservation factors and methods for and products of their use |
| US20020169128A1 (en) * | 2001-04-09 | 2002-11-14 | Geroge Sigounas | Erythropoietin ameliorates chemotherapy-induced toxicity in vivo |
| KR100473422B1 (ko) * | 2003-06-12 | 2005-03-14 | 박원봉 | 렉틴 함유 천연물의 장용성 코팅용 조성물 |
| PL375746A1 (pl) * | 2005-06-16 | 2006-12-27 | Biolek Sp Z Oo | Sposób otrzymywania preparatu lektynowego, preparat lektynowy oraz sposób podawania preparatu lektynowego dla ssaków |
| EP2106705B1 (de) | 2008-04-02 | 2012-01-04 | Helvista AG | Verwendung einer Zusammensetzung, welche ein Pflanzenlektin, ein proteolytisches Enzym und eine Selenverbindung umfasst, zum Schleimhautschutz und zur Linderung anderer Symptome bei Krebspatienten |
| EP2218456B1 (de) * | 2009-02-10 | 2011-03-16 | Helvista AG | Lektinzusammensetzung zur Prophylaxe und/oder Behandlung von unerwünschten Arzneimittelnebenwirkungen |
| DE102010033458B4 (de) | 2010-08-05 | 2016-03-10 | Helvista Ag | Emulgierte Lektinzusammensetzungen und ihre Verwendung |
| CN103068263A (zh) * | 2010-08-12 | 2013-04-24 | 百奥莱克有限公司 | 从普通豆类提取凝集素的方法以及凝集素制剂 |
| EP2675275B1 (de) * | 2011-02-14 | 2017-12-20 | The Regents Of The University Of Michigan | Zusammensetzungen und verfahren zur behandlung von adipositas und damit zusammenhängenden erkrankungen |
| US8946424B2 (en) | 2013-05-02 | 2015-02-03 | The Regents Of The University Of Michigan | Deuterated amlexanox |
| EP3407974A4 (de) | 2016-01-29 | 2019-08-28 | The Regents Of The University Of Michigan | Amlexanox-analoga |
| EP3243523B1 (de) | 2016-05-11 | 2020-04-29 | YACARE GmbH | Lektine und krebsprophylaxe |
| US10918695B2 (en) | 2019-01-03 | 2021-02-16 | The Secretary, Department Of Atomic Energy | Use of jack bean lectin for increasing the abundance of hematopoietic stem cells and progenitor cells in bone marrow and/or epidermal stem cells in skin in vivo |
| EP3701967B1 (de) | 2019-02-26 | 2025-07-30 | The Secretary, Department Of Atomic Energy | Verwendung von schwertbohnenlectin zur erhöhung der menge hämatopoietischer stammzellen und vorläuferzellen in knochenmark und/oder epidermaler stammzellen in der haut in vivo |
| GB201903244D0 (en) | 2019-03-14 | 2019-04-24 | Syndermix Ag | Methods for lectin production with improved yield |
| CN110433280A (zh) * | 2019-09-11 | 2019-11-12 | 周口师范学院 | 植物血凝素在制备预防或治疗肥胖药物中的应用 |
| CN112707958B (zh) * | 2020-12-26 | 2023-08-29 | 郑州伊美诺生物技术有限公司 | 一种提取l型和e型植物凝集素的方法 |
| CN117858717A (zh) * | 2021-08-30 | 2024-04-09 | 联合化学实验室有限公司 | 用于治疗炎症性疾病的蛋白质组合物 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5053386A (en) * | 1987-07-24 | 1991-10-01 | Tung Ta C | Orally administrable anti-metastatic lectin compositions and methods |
| DE4318307A1 (de) * | 1993-06-02 | 1994-12-08 | Ludwig Dr Rer Nat Habil Jonas | Einsatz von Lektinen zur Therapie der akuten und chronischen Pankreatitis des Menschen |
-
1996
- 1996-06-21 GB GBGB9613070.3A patent/GB9613070D0/en active Pending
-
1997
- 1997-06-20 RU RU99100724/14A patent/RU2202361C2/ru not_active IP Right Cessation
- 1997-06-20 WO PCT/GB1997/001668 patent/WO1997049420A1/en not_active Ceased
- 1997-06-20 DE DE69717849T patent/DE69717849T2/de not_active Expired - Lifetime
- 1997-06-20 NZ NZ333411A patent/NZ333411A/xx not_active IP Right Cessation
- 1997-06-20 PL PL97330865A patent/PL190301B1/pl not_active IP Right Cessation
- 1997-06-20 JP JP50252498A patent/JP4379924B2/ja not_active Expired - Fee Related
- 1997-06-20 ES ES97927282T patent/ES2190535T3/es not_active Expired - Lifetime
- 1997-06-20 DK DK97927282T patent/DK0942741T3/da active
- 1997-06-20 EP EP97927282A patent/EP0942741B1/de not_active Revoked
- 1997-06-20 AU AU31832/97A patent/AU738386B2/en not_active Ceased
- 1997-06-20 CN CNB971968373A patent/CN1157225C/zh not_active Expired - Fee Related
- 1997-06-20 PT PT97927282T patent/PT942741E/pt unknown
- 1997-06-20 CA CA002258503A patent/CA2258503C/en not_active Expired - Fee Related
- 1997-06-20 AT AT97927282T patent/ATE229341T1/de not_active IP Right Cessation
-
1998
- 1998-12-18 NO NO19985980A patent/NO323880B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| ES2190535T3 (es) | 2003-08-01 |
| AU738386B2 (en) | 2001-09-20 |
| NO323880B1 (no) | 2007-07-16 |
| PL330865A1 (en) | 1999-06-07 |
| DE69717849D1 (de) | 2003-01-23 |
| GB9613070D0 (en) | 1996-08-28 |
| NZ333411A (en) | 2000-08-25 |
| AU3183297A (en) | 1998-01-14 |
| EP0942741A1 (de) | 1999-09-22 |
| JP2001510447A (ja) | 2001-07-31 |
| RU2202361C2 (ru) | 2003-04-20 |
| CA2258503C (en) | 2009-08-11 |
| NO985980L (no) | 1999-02-19 |
| WO1997049420A1 (en) | 1997-12-31 |
| DK0942741T3 (da) | 2003-04-07 |
| PT942741E (pt) | 2003-04-30 |
| NO985980D0 (no) | 1998-12-18 |
| CN1157225C (zh) | 2004-07-14 |
| EP0942741B1 (de) | 2002-12-11 |
| CA2258503A1 (en) | 1997-12-31 |
| JP4379924B2 (ja) | 2009-12-09 |
| DE69717849T2 (de) | 2003-11-13 |
| CN1230891A (zh) | 1999-10-06 |
| PL190301B1 (pl) | 2005-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69717849D1 (de) | Lektinzusammenstellungen und deren verwendung | |
| TR199901172T2 (xx) | Yeni ikame edilmi� pirazol t�revleri. | |
| FR2754820B1 (fr) | Le (-)hydroxycitrate de magnesium, procede de preparation, applications, et compositions notamment pharmaceutiques le renfermant | |
| AU5225498A (en) | Biaromatic compounds, pharmaceutical and cosmetic compositions containing them and uses thereof | |
| ATE208384T1 (de) | Verwendung von ascorbyl-gamma-linolenat und von ascorbyl-dihomo-gamma-linolenat zur behandlung von asthma, krebs, kardiovaskulären und inflammatorischen erkrankungen | |
| NZ328874A (en) | Heterocyclic biaryl compounds and their use in pharmaceutical compositions for treatment of dermatological, rheumatic, respiratory, cardiovascular and ophthalmological disorders | |
| MX9708803A (es) | Compuestos biaromaticos de propinilo o dienilo. | |
| TR200002248T2 (tr) | Yeni dihidroksiheksanoik asit türevleri | |
| NZ510153A (en) | Tan-1057 derivatives with reduced toxicity and their use in medicaments for treating bacterial infections in humans and mammals | |
| BG101126A (en) | The use of muramylpeptide compounds | |
| DE59107336D1 (de) | Oligosaccharidderivate und deren Verwendung in Heilmitteln | |
| BR9904890A (pt) | "compostos de heteroetinileno, composição farmacêutica, composição cosmética e utilização de uma composição cosmética" | |
| BR9607996A (pt) | Derivado de aminotetralina para o tratamento de doenças cardiovasculares | |
| DE69003960D1 (de) | Die Verwendung von deacetyliertem Chitin zur Herstellung eines Medikamentes für die Behandlung von entzündliche Krankheiten. | |
| ATE206052T1 (de) | Verwendung von sphingosin-1-phosphat, sphingosin- 1-phosphat-derivaten und/oder deren gemische zur behandlung von entzündlichen hautkrankheiten | |
| ATE241640T1 (de) | Fusidinsäure-derivate | |
| GEU1998374Y (en) | Method for Receiving Means for Treatment of Cardiovascular Diseases | |
| DK64494A (da) | Balsam mod psoriasis | |
| UA32111A (uk) | Спосіб одержання препарату для лікування захворювань опорно-рухового апарату |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 0942741 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |